Attached files

file filename
EX-10.13 - EXHIBIT 10.13 - QUEST DIAGNOSTICS INCdgx12312015ex1013.htm
EX-10.11 - EXHIBIT 10.11 - QUEST DIAGNOSTICS INCdgx12312015ex1011.htm
10-K - 10-K - QUEST DIAGNOSTICS INCdgx1231201510-k.htm
EX-10.3 - EXHIBIT 10.3 - QUEST DIAGNOSTICS INCdgx12312015ex103.htm
EX-31.2 - EXHIBIT 31.2 - QUEST DIAGNOSTICS INCdgx12312015ex312.htm
EX-32.1 - EXHIBIT 32.1 - QUEST DIAGNOSTICS INCdgx12312015ex321.htm
EX-32.2 - EXHIBIT 32.2 - QUEST DIAGNOSTICS INCdgx12312015ex322.htm
EX-31.1 - EXHIBIT 31.1 - QUEST DIAGNOSTICS INCdgx12312015ex311.htm
EX-21.1 - EXHIBIT 21.1 - QUEST DIAGNOSTICS INCdgx12312015ex211.htm
EX-10.15 - EXHIBIT 10.15 - QUEST DIAGNOSTICS INCdgx12312015ex1015.htm
EX-10.12 - EXHIBIT 10.12 - QUEST DIAGNOSTICS INCdgx12312015ex1012.htm


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-188947) and Form S-8 (Nos. 333-184580, 333-182863, 333-143889, 333-136196, 333-136195, 333-60758, 333-60477, 333-157447, 333-162710, 333-162711 and 333-207746) of Quest Diagnostics Incorporated of our report dated February 26, 2016 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


By
/s/ PricewaterhouseCoopers LLP
 
 
 
PricewaterhouseCoopers LLP
 
 
 
Florham Park, New Jersey
 
February 26, 2016